InvestorsHub Logo
icon url

Traderfan

03/08/13 2:17 PM

#8289 RE: 10 bagger #8288

CBHMF, are you aware that they are listed on the grey sheets?
icon url

zenvesting

03/10/13 10:09 AM

#8295 RE: 10 bagger #8288

RX.v/BIOYF.pk: Biosyent Presentation from the Microcap Club Invitational:

http://microcapclub.com/2013/02/microcapclub-invitational-biosyent-rx-v/#more-2259

Strong trailing results and a strong plan for continued growth.

As interesting as CPHMF looks, I won't be selling any RX.v to buy it, but might pear down some other positions to buy some.

icon url

10 bagger

03/26/13 1:49 PM

#8347 RE: 10 bagger #8288

CPHMF.. $3.5849 USD.. S
icon url

btmfdr2

05/06/13 12:26 PM

#8476 RE: 10 bagger #8288


CPHMF - I bought more this morning. I paused after buying my initially figuring I'd wait for a pullback which never came.

According to the CC the Isotrenton market in the U.S. has grown to $800MM of which Absorbica is at 7.5% market share right now after five months on the market. I think peak sales of Absorbica could be much higher than the $200MM figure in Jason Napadono's March Zachs report. Being the only promoted Isotrenton in the US, and having the dosing flexibility, I don't see why this shouldn't become bigger than Clarivis which is a $350MM product.

A double this year should be easy. This is easy money.